2Amobi N,Guillebaud J,Coker C,et al.Functional characterization of alpha1-adrenoceptor subtypes in longitudinal and circular muscle of human vas deferens[J]. Eur J Pharmacol, 1999, 367(2-3):291-298.
3Lepor H, Tang R, Shapiro E. The alpha-adrenoceptor subtype mediating the tension of human prostatic smooth muscle[J]. Prostate, 1993, 22(4):301-307.
5Muramatsu I, Taniguchi T, Okada K. Tamsulosin:alpha-adrenoceptor subtype-selectivity and comparison with terazosin[J]. Jpn J Pharmacol, 1998, 78(3):331-335.
6Yoshiyama M, De Groat WC. Role of spinal alpha1-adrenoceptor subtypes in the bladder reflex in anesthetized rats[J]. Am J Physiol Regul Integr Comp Physiol, 2001, 280(5):R1414-R1419.
7Lepor H,Jones K,Williford W. The mechanism of adverse events associated with terazosin:an analysis of the Veterans Affairs cooperative study[J]. J Urol, 2000, 163(4):1134-1137.
二级参考文献14
1Nomiya M, Yamaguchi O. A quantitative analysis of mRNA expression of alpha 1 and beta-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders [ J ]. J Urol, 2003, 170(2 Pt 1 ) :649-653.
2Yamamoto T, Ghosh R, De Groat WC, et al. Facilitation of transmitter release in the urinary bladders of neonatal and adult rats via alphal-adrenoceptors [ J ]. Eur J Pharmacol, 2001,414 ( 1 ) :31-35.
3Yashiyama M, De Groat WC. Role of spinal alphal -adrenoceptor subtypes in the bladder reflex in anesthetized rats [ J]. Am J Physiol Regul Integr Comp Physiol, 2001, 280 (5): R1414-1419.
4Hayashi T, Sakai Y, Saito K, et al. A comparative study assessing clinical effects of naftopidil and tamsulosin hydrochloride on benign prostatic hyperplasia[ J]. Hinyokika Kiyo, 2002,48(1):7-11.
5Lepor H, Jones K, Williford W. The mechanism of adverse events associated with terazosin: an analysis of the Veterans Affairs cooperative study[J]. J Urol, 2000, 163(4) :1134-1137.
6Michel MC, Flannery MT, Narayan P. Worldwide experience with alfuzosin and tamsulosin [ J ]. Urology, 2001,58 (4) :508-516.
7Roehrboru CG. Alfuzosin:overview of pharmacokinetics,safety and efficacy of a clinically uroselective alpha-blocker [ J ]. Urology,2001,58(6 Suppl 1 ):55-63.
8Mottet N, Bressolle F, Delmas V, et al. Prostatic tissual distribution of alfuzosin in patients with benign prostatic hyperplasia following repeated oral administration [ J ]. Eur Urol, 2003, 44(1) :101-105.
9Lepor H, Tang R, Shapiro E. The alpha-adrenoceptor subtype mediating the tension of human prostatic smooth muscle [ J ].Prostate, 1993, 22(4) :301-307.
10Walden PD, Gerardi C, Lepor H. Localization and expression of the alphal A-1, alphal B, alphal D-adrenoceptors in hyperplastic and non-hyperplastic human prostate [ J]. J Urol, 1999, 161(2) :635-640.
